美國的血糖監測市場分析 是由出版商RNCOS E-Services Pvt. Ltd.在2011年11月所出版的。
這份英文市場調查報告書包含55 Pages 價格從美金1000起跳。
糖尿病是美國蔓延最廣的疾病之一，2010年推測病患人數有2700萬人。再者未接受診療的糖尿病患者可能還有更多，但一般相信血糖監測設備和血糖值的自我檢測設備等的開發與普及，應可解決這個問題。美國的血糖監測設備市場預測從2010年~∼2015年將達成8%的成長。
本報告提供美國的血糖監測市場相關分析，整體市場結構和最新的技術·市場趨勢，推動及阻礙市場要素，各個檢測設備市場概況，法規環境，再加上主要企業簡介等資訊彙整，為您概述為以下內容。
第1章 分析師的見解
第2章 分析方法
第3章 血糖監測系統:簡介
第4章 血糖監測技術
- 酵素·測光檢測
- Amperometric檢測
- 熒光技術
- 逆電離子導入
第5章 推動及阻礙市場要素
第6章 美國的糖尿病市場概況
第7章 血糖監測設備市場
第8章 法規環境
第9章 主要企業
- Roche
- LifeScan
- Bayer
- Abbott Laboratories
- Medtronic Diabetes
圖表一覽
Abstract
The US has a dominant share in the global diabetes market with 90-95% of the
diabetic patients in the country suffering from type-II diabetes. Factors
like, high prevalence of diabetes, rising aging population and the increasing
incidence of diabetes associated with Western diets have contributed to such
stupendous escalation of the diabetes population in the US, further affecting
the market for glucose monitoring devices in the country.
According to the report, " US Glucose Monitoring Market Analysis" , the
glucose monitoring market in the country is expected to grow at a CAGR of
approximately 8% during 2010-2015. Factors, such as steady increase in the
number of people diagnosed with diabetes, along with intensive management and
treatment processes/procedures are expected to sustain a high market growth
rate in the glucose monitoring market. Additionally, from product categories,
including blood glucose test strips, monitors, and lancet/lancet devices are
expected to register significant growth rates.
Our industry research disclosed that the US market for glucose monitoring is
highly competitive. Leading players in the US offering blood glucose
monitoring and testing systems include Abbott Diabetes Care, Bayer Healthcare,
LifeScan, Medtronic, and Roche Diagnostics. Further, Glucometer DEX, AccuChek,
One Touch, and SureStep are some leading brands of the global market.
According to " US Glucose Monitoring Market Analysis" , the US glucose
monitoring market was analyzed, by segmenting it into glucose strips, blood
glucose meters, continuous glucose meter, and lancets. Each of these sectors
have been thoroughly studied and analyzed in the report. Also, the report
gives an overview of the patient profile and cost implications of diabetes in
the country, which will help customers in determining the future demand
scenario.
Table of Contents
1. Analyst View
2. Research Methodology
3. Glucose Monitoring Systems: An Introduction
4. Glucose Monitoring Technologies
- 4.1 Enzyme-Photometric Sensing
- 4.2 Amperometric Sensing
- 4.3 Fluorescence Technology
- 4.4 Reverse Iontophoresis
5. Market Drivers & Restraints
6. US: Diabetes Market Overview
7. Glucose Monitoring Devices Market
- 7.1 Blood Glucose Meter
- 7.1.1 Market Size
- 7.1.2 Key Products & Players
- 7.1.3 Product Introductions
- 7.2 Continuous Blood Glucose Monitors
- 7.2.1 Market Size
- 7.2.2 Key Products & Players
- 7.3 Glucose Test Strips
- 7.3.1 Market Size
- 7.3.2 Key Products & Players
- 7.4 Lancets
- 7.4.1 Market Size
- 7.4.2 Key Products & Players
- 7.4.3 Product Introductions
8. Regulatory Environment
9. Key Players
- 9.1 Roche
- 9.2 LifeScan
- 9.3 Bayer
- 9.4 Abbott Laboratories
- 9.5 Medtronic Diabetes
List of Figures:
- Figure 6-1: Prevalence of Diabetes (%), 2010 & 2030
- Figure 6-2: Number of Diabetic Population (Million), 2010 & 2030
- Figure 7-1: Glucose Monitoring Market (Billion US$), 2010-2015
- Figure 7-2: Glucose Monitoring Market by Segment (%), 2010
- Figure 7-3: Share of Diabetic Population Using Blood Glucose Monitors
(2010)
- Figure 7-4: Blood Glucose Meter Market (Million US$), 2010-2015
- Figure 7-5: Continuous Blood Glucose Monitoring Market (Million US$),
2010-2015
- Figure 7-6: Glucose Test Strips Market (Billion US$), 2010-2015
- Figure 7-7: Test Strips Prices by Manufacturers (US$ per 100)
- Figure 7-8: Lancets Market (Million US$), 2010-2015
List of Tables:
- Table 6-1: Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
- Table 6-2: Health Costs on Pre-diabetes/Diabetes by Primary Source of
Coverage (Billion US$), 2010 & 2011-2020
- Table 6-3: Spending for Pre-diabetes/Diabetes by Federal Government and
States (Billion US$), 2011 to 2020
- Table 7-1: List of Blood Glucose Meters by Manufacturers
- Table 7-2: Key Continuous Glucose Monitoring Products by Manufacturers
(2011)
- Table 7-3: Pipeline Products for Continuous Glucose Monitors
- Table 7-4: List of Lancets & Lancing Devices by Manufacturers
